Under the extension, approximately 130,000 women in the target population of 50 to 64 years of age will be eligible for screening. The programme expects to diagnose approximately 400 cancers per annum among this population. Under the business plan submitted by BreastCheck to the Department, the national expansion of the programme to the west and south has been costed at €27 million, including €13 million in capital costs. Discussions are ongoing involving officials at the Department, BreastCheck and relevant health agencies in relation to the detailed implementation of the programme.